Cargando…
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Ever since the discovery of vaccines, many deadly diseases have been contained worldwide, ultimately culminating in the eradication of smallpox and polio, which represented significant medical achievements in human health. However, this does not account for the threat influenza poses on public healt...
Autores principales: | Sayedahmed, Ekramy E., Elkashif, Ahmed, Alhashimi, Marwa, Sambhara, Suryaprakash, Mittal, Suresh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712206/ https://www.ncbi.nlm.nih.gov/pubmed/33019589 http://dx.doi.org/10.3390/vaccines8040574 |
Ejemplares similares
-
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021) -
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
por: Alhashimi, Marwa, et al.
Publicado: (2021) -
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018) -
Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022) -
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
por: Hassan, Ahmed O., et al.
Publicado: (2017)